Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine if there are significant interactions
between oral lorcaserin treatment concurrent with 20 and 40 mg intravenous (i.v.) cocaine
infusions by measuring adverse events (AEs) and cardiovascular responses including heart rate
(HR), blood pressure (BP), and electrocardiogram (ECG) (including QTc).